Genetic testing for familial hypercholesterolemia listed on the Medicare Benefits Schedule
11 May, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that genetic testing for heritable mutations associated with Familial Hypercholesterolemia (FH) is now listed on the Medicare Benefits Schedule (MBS). This addition to the MBS follows an application by the RCPA to the Medical Services Advisory Committee (MSAC).
Go Back

Page last updated:

Copyright © 2020 RCPA. All rights reserved.

11-May-2020
Top